Literature DB >> 19481066

Bz-423 superoxide signals B cell apoptosis via Mcl-1, Bak, and Bax.

Neal B Blatt1, Anthony E Boitano, Costas A Lyssiotis, Anthony W Opipari, Gary D Glick.   

Abstract

Bz-423 is a pro-apoptotic 1,4-benzodiazepine with therapeutic properties in murine models of lupus demonstrating selectivity for autoreactive lymphocytes. Bz-423 modulates the F(1)F(0)-ATPase, inducing the formation of superoxide within the mitochondrial respiratory chain, which then functions as a second messenger initiating apoptosis. In order to understand some of the features that contribute to the increased sensitivity of lymphocytes, we report the signaling pathway engaged by Bz-423 in a Burkitt lymphoma cell line (Ramos). Following the generation of superoxide, Bz-423-induced apoptosis requires the activation of Bax and Bak to induce mitochondrial outer membrane permeabilization and cytochrome c release. Knockdown of the BH3-only proteins Bad, Bim, Bik, and Puma inhibits Bz-423 apoptosis, suggesting that these proteins serve as upstream sensors of the oxidant stress induced by Bz-423. Treatment with Bz-423 results in superoxide-dependent Mcl-1 degradation, implicating this protein as the link between Bz-423-induced superoxide and Bax and Bak activation. In contrast to fibroblasts, B cell death induced by Bz-423 is independent of c-Jun N-terminal kinase. These results demonstrate that superoxide generated from the mitochondrial respiratory chain as a consequence of a respiratory transition can signal a specific apoptotic response that differs across cell types.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19481066      PMCID: PMC2759512          DOI: 10.1016/j.bcp.2009.05.025

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  31 in total

Review 1.  Pharmacological manipulation of cell death: clinical applications in sight?

Authors:  Douglas R Green; Guido Kroemer
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

2.  Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis.

Authors:  Qing Zhong; Wenhua Gao; Fenghe Du; Xiaodong Wang
Journal:  Cell       Date:  2005-07-01       Impact factor: 41.582

Review 3.  Role of MAPKs in development and differentiation: lessons from knockout mice.

Authors:  M Aouadi; B Binetruy; L Caron; Y Le Marchand-Brustel; F Bost
Journal:  Biochimie       Date:  2006-06-27       Impact factor: 4.079

Review 4.  Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario.

Authors:  J E Chipuk; L Bouchier-Hayes; D R Green
Journal:  Cell Death Differ       Date:  2006-05-19       Impact factor: 15.828

5.  Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1.

Authors:  Ulrich Maurer; Céline Charvet; Allan S Wagman; Emmanuel Dejardin; Douglas R Green
Journal:  Mol Cell       Date:  2006-03-17       Impact factor: 17.970

Review 6.  Life in the balance: how BH3-only proteins induce apoptosis.

Authors:  Simon N Willis; Jerry M Adams
Journal:  Curr Opin Cell Biol       Date:  2005-10-21       Impact factor: 8.382

Review 7.  Redefining oxidative stress.

Authors:  Dean P Jones
Journal:  Antioxid Redox Signal       Date:  2006 Sep-Oct       Impact factor: 8.401

8.  2-Methoxyestradiol-induced apoptosis in human leukemia cells proceeds through a reactive oxygen species and Akt-dependent process.

Authors:  Ning Gao; Mohamed Rahmani; Paul Dent; Steven Grant
Journal:  Oncogene       Date:  2005-05-26       Impact factor: 9.867

9.  The immunomodulatory benzodiazepine Bz-423 inhibits B-cell proliferation by targeting c-myc protein for rapid and specific degradation.

Authors:  Thomas B Sundberg; Gina M Ney; Chitra Subramanian; Anthony W Opipari; Gary D Glick
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

10.  Identification and validation of the mitochondrial F1F0-ATPase as the molecular target of the immunomodulatory benzodiazepine Bz-423.

Authors:  Kathryn M Johnson; Xueni Chen; Anthony Boitano; Lara Swenson; Anthony W Opipari; Gary D Glick
Journal:  Chem Biol       Date:  2005-04
View more
  7 in total

1.  Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine ('ecstasy') through iterative chemical redesign: mechanisms and pathways to cell death.

Authors:  Agata M Wasik; Michael N Gandy; Matthew McIldowie; Michelle J Holder; Anita Chamba; Anita Challa; Katie D Lewis; Stephen P Young; Dagmar Scheel-Toellner; Martin J Dyer; Nicholas M Barnes; Matthew J Piggott; John Gordon
Journal:  Invest New Drugs       Date:  2011-08-18       Impact factor: 3.850

Review 2.  The metabolic life and times of a T-cell.

Authors:  Ryan D Michalek; Jeffrey C Rathmell
Journal:  Immunol Rev       Date:  2010-07       Impact factor: 12.988

3.  ABT-263 enhances sorafenib-induced apoptosis associated with Akt activity and the expression of Bax and p21((CIP1/WAF1)) in human cancer cells.

Authors:  Jingru Li; Yicheng Chen; Jiali Wan; Xin Liu; Chunrong Yu; Wenhua Li
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

Review 4.  Distinct metabolic programs in activated T cells: opportunities for selective immunomodulation.

Authors:  Daniel R Wahl; Craig A Byersdorfer; James L M Ferrara; Anthony W Opipari; Gary D Glick
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

5.  Apoptotic signaling activated by modulation of the F0F1-ATPase: implications for selective killing of autoimmune lymphocytes.

Authors:  Thomas B Sundberg; Lara Swenson; Daniel R Wahl; Anthony W Opipari; Gary D Glick
Journal:  J Pharmacol Exp Ther       Date:  2009-08-25       Impact factor: 4.030

6.  BH3-only protein Bik is involved in both apoptosis induction and sensitivity to oxidative stress in multiple myeloma.

Authors:  L Bodet; E Ménoret; G Descamps; C Pellat-Deceunynck; R Bataille; S Le Gouill; P Moreau; M Amiot; P Gomez-Bougie
Journal:  Br J Cancer       Date:  2010-11-09       Impact factor: 7.640

Review 7.  Visualizing Mitochondrial FoF1-ATP Synthase as the Target of the Immunomodulatory Drug Bz-423.

Authors:  Ilka Starke; Gary D Glick; Michael Börsch
Journal:  Front Physiol       Date:  2018-07-04       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.